Table 1.
Primer pairs for real-time PCR.
Table 2.
Effects of DECB serum ALT and AST activities in mice with CCl4-induced liver injury.
Table 3.
Effects of DECB on GSH, MDA and T-SOD in liver tissues of mice with CCl4-induced liver injury.
Fig 1.
HE staining of the liver cells of mice (HE100×).
(A: blank control group; B: model group; C: DECB group; D: positive control group).
Fig 2.
TUNEL staining of the liver of mice cells (×400).
(A: blank control group; B: model group; C: DECB group; D: positive control group).
Table 4.
Effect of DECB on the hepatocyte apoptosis index in mice with CCl4-induced liver injury (n = 10, mean±SD).
Fig 3.
Weston blot validation of caspase-8, caspase-3 and caspase-9.
*P<0.05 vs. blank control group, #P<0. 05 vs. model group. (CON, blank control group; M, model group; DECB, deproteinized extract of calf blood group; PC, positive control group).
Fig 4.
Results of mRNA expression profile microarray analysis.
(M, model group; DECB, deproteinized extract of calf blood group).
Table 5.
Differential expression of genes in the apoptotic pathway based on the mRNA microarray.
Table 6.
Related diseases of IPA analysis.
Table 7.
Related biofunctions of IPA.
Table 8.
Results of real-time quantitative PCR validation.
Fig 5.
Real-time quantitative PCR validation of the Fas, IL1b, Pik3r1, Pik3r5, and Traf2 genes.
*P<0.05, **P<0.01, DECB group vs. model group (M, model group; DECB, deproteinized extract of calf blood group).